RT @AnnSurgOncol: EDITORIAL: When Is Watchful Waiting Warranted? Advances in #SoftTissueSarcoma—An Editorial Commentary. https://t.co/oxJas…
RT @AnnSurgOncol: EDITORIAL: When Is Watchful Waiting Warranted? Advances in #SoftTissueSarcoma—An Editorial Commentary. https://t.co/oxJas…
RT @AnnSurgOncol: EDITORIAL: When Is Watchful Waiting Warranted? Advances in #SoftTissueSarcoma—An Editorial Commentary. https://t.co/oxJas…
RT @AnnSurgOncol: EDITORIAL: When Is Watchful Waiting Warranted? Advances in #SoftTissueSarcoma—An Editorial Commentary. https://t.co/oxJas…
RT @AnnSurgOncol: EDITORIAL: When Is Watchful Waiting Warranted? Advances in #SoftTissueSarcoma—An Editorial Commentary. https://t.co/oxJas…
RT @AnnSurgOncol: EDITORIAL: When Is Watchful Waiting Warranted? Advances in #SoftTissueSarcoma—An Editorial Commentary. https://t.co/oxJas…
RT @AnnSurgOncol: EDITORIAL: When Is Watchful Waiting Warranted? Advances in #SoftTissueSarcoma—An Editorial Commentary. https://t.co/oxJas…
RT SocSurgOnc RT AnnSurgOncol: EDITORIAL: When Is Watchful Waiting Warranted? Advances in #SoftTissueSarcoma—An Editorial Commentary. https://t.co/lcHcaUnvp7 McMastersKelly SocSurgOnc
RT @AnnSurgOncol: EDITORIAL: When Is Watchful Waiting Warranted? Advances in #SoftTissueSarcoma—An Editorial Commentary. https://t.co/oxJas…
RT @AnnSurgOncol: EDITORIAL: When Is Watchful Waiting Warranted? Advances in #SoftTissueSarcoma—An Editorial Commentary. https://t.co/oxJas…
RT @AnnSurgOncol: EDITORIAL: When Is Watchful Waiting Warranted? Advances in #SoftTissueSarcoma—An Editorial Commentary. https://t.co/oxJas…
EDITORIAL: When Is Watchful Waiting Warranted? Advances in #SoftTissueSarcoma—An Editorial Commentary. https://t.co/oxJasFNh6H @McMastersKelly @SocSurgOnc
RT @RazaSayyed12: Watchful waiting in R1 unplanned excision for extremity and truncal sarcomas. Excellent editorial calling for collaborati…
RT @RazaSayyed12: Watchful waiting in R1 unplanned excision for extremity and truncal sarcomas. Excellent editorial calling for collaborati…
Watchful waiting in R1 unplanned excision for extremity and truncal sarcomas. Excellent editorial calling for collaborative research from #sarcoma centers. https://t.co/ldWDtOqyv6